menu
Join a Panel FOR COMPANIES
  • By Practice
  • Product Innovation
  • Qualitative Research
  • Customer Experience
  • Thought Leadership
  • Strategic Sales
  • By Topic
  • CPG
  • Healthcare
  • Innovation
  • Manufacturing
  • Technology
  • Resources
close

Start a Guild™

Karen Facey
Talks (0)
Industry and Policy Updates: HIPAA Compliance and Enforcement for Alarming Trends in Data Safety
Frontiers | Hypercaloric low-carbohydrate high-fat diet protects against the development of nonalcoholic fatty liver disease in obese mice in contrast to isocaloric Western diet
How dentistry relates to digital health and access to health.? | 4 Answers from Research papers
Who Benefits from Direct-to-Consumer Pharmaceutical Advertising? : UMass AmherstSearchCloseCopy URLShare on FacebookShare on TwitterShare via EmailPrint
Epidemiology Intelligence | Clarivate
Technical and Legal Criteria for Assessing Cloud Trustworthiness | ITIF
What Is Change Management? | Definition from TechTarget
What are the opportunities presented by technology in medical field? | 5 Answers from Research papers
Stanford Cancer Institute
How Pharma Tokenization is Revolutionizing the Fight Against Counterfeit Medicines | by Spydra | Mar, 2024 | Medium
Pitches (0)
add
Karen Facey
close

Total Points: 49

Earned By

close

Edit Partner Bio

close

Add Position

close

Add Education

Start Year
End Year
close

Profile



close

Profile

Current title:

Current company:

Profile Summary:

Facebook:

Linkedin:

Instagram:

close

Partner Description

close
Edit skills
close
Edit skills
close

Make your own Post

Description
Tell everyone what your Post is about


Banner Image




close

FOLLOWERS ()

close

Edit your post

close

EDIT APPLICATION

close

arrow_back Add tags to your Talk

Tags help us put your talk in the eyes of people that could be potentially interested in participating

Add at least 3 tags
Your tags
close

Start a Talk

Share articles, books, podcasts, ideas or questions that you think are important for other professionals to stay fresh and relevant.

close
Karen Facey

Karen Facey

Evidence Based Health Policy Consultant

Comments
Keep the conversation going

close
arrow_back

Add talk to Currnt

Karen Facey

Karen Facey

Evidence Based Health Policy Consultant

Joined 09/12/2016

Level: LEVEL 01 (12 mo pts: 0 pts)

Lifetime points: 49 pts

Following a career as a statistician in the pharmaceutical industry and medicines regulation, Karen entered the field of Health Technology Assessment (HTA). HTA is a multidisciplinary policy analysis of the medical, social, ethical and economic impacts of the introduction, diffusion and disinvestment of health interventions. Karen is passionate about holistic assessment of the impact of interventions in health systems using robust evidence in a variety of forms to inform accountable decision making. This is not just an academic interest, as a Non Executive Director in a Scottish health board for 8 years Karen was also fully aware of the real-life challenges in setting health care priorities when budgets are limited and efficency pressures increase. She also chaired the government committee that created the new funding formula for the NHS (NRAC). She has a critical eye for value assessment and is an engaging presenter and experienced facilitator.

In 2014, Karen was named as one of the top 100 practising scientists in the UK.

Specialties: Statistics,
Health Technology Assessment (HTA)
Health provision
Health policy
Patient involvement in HTA
close

Pitch an Idea

In 20 seconds, make an introduction, an ask, a pitch, a question, or invite others to collaborate with you on a related topic.

Add Title:
Record:
Add 2+ tags
Suggested tags
close

Total Points: